I bring extensive experience navigating multi-jurisdictional IP and regulatory requirements for pharmaceuticals and biologics, gained through working on both the branded and generic sides of the pharmaceutical industry. This dual perspective enables me to craft tailored IP, life-cycle management, and portfolio-planning strategies for pharmaceutical and life-science companies.